Picture a chemist sitting across from his accountant at the end of Q2. The books say the pharmacy is profitable. But when they pull the GSTR-1 detail, a quarter's Ayurvedic sales have been filed under the wrong HSN code — the same code used for the allopathy shelf. The code was right for the Schedule H strips but wrong for the classical formulations sitting three feet away. If a notice follows, the rectification can cost more than the tax itself, mostly in CA time and lost sleep.
Dual-category pharmacies — both allopathy and Ayurveda on one counter — are common across India, and in many of them this billing gap is baked into the daily workflow. The pharmacist at the counter doesn't think in tax categories. He thinks in customer queues. And the software he's using wasn't built to think in two regulatory worlds at once.
If you run a pharmacy that stocks both Ayurvedic and allopathic medicines and you're billing them through the same screen without category separation, you may be filing incorrect returns today. That's the stake. What follows is the cost, piece by piece.
Your GST Filing Has a Structural Error You May Not See Until a Notice Arrives
Pick up any Dabur Ashwagandha capsule from your Ayurveda shelf and any Cipla Azithromycin strip from your allopathy rack. Both are sold to the same customer. Both go into the same bill. But they belong to different HSN families and, depending on formulation and registration, may carry different GST treatment under the rates in force since 22 September 2025, after the 56th GST Council.
Classical Ayurvedic formulations listed in the Ayurvedic Pharmacopoeia of India often fall under HSN 3004 at 5% GST — the same broad heading as allopathy — but the specific sub-classification and any applicable exemptions differ by product type. Proprietary AYUSH products sometimes carry a different effective rate. When a billing system applies a blanket HSN 3004 at 5% to everything because that's what the software defaulted to for allopathy, the sub-classification errors accumulate across every invoice.
Over a year, even a small per-unit misclassification adds up to a reconciliation headache of correction work, possible penalties, and professional fees. The tax itself may be small. The paperwork to fix it is not.
The Schedule H Register Doesn't Know What to Do With Ashwagandha
Rule 65 of India's Drugs and Cosmetics Rules requires every Schedule H and H1 supply to be recorded — in a prescription register or on a serially numbered cash or credit memo — and Schedule H1 supplies also in a separate register, kept for three years. Selling a Schedule H1 drug without a prescription is punishable under Section 27(d) of the Drugs and Cosmetics Act, 1940: imprisonment of one to two years and a fine of not less than ₹20,000.
The problem in a dual-stock pharmacy is that allopathy and AYUSH medicines are regulated under different schedules and different drug lists. AYUSH medicines containing the ingredients listed in Schedule E(1) carry their own labelling rules. A billing system designed purely for allopathy either misses these AYUSH-specific entries entirely or lumps them into the allopathy register incorrectly.
A common workaround is a separate handwritten notebook kept behind the counter for AYUSH restricted products. That notebook is not searchable. It cannot be audited quickly. If an inspector walks in, a manual record kept in a rush is likely to have gaps.
AYUSH Billing Rules Are Different, and Your Counter Staff May Not Know
AYUSH billing in a retail pharmacy context carries specific requirements when dealing with proprietary products versus classical formulations — different label requirements, different batch documentation, and in some states, different licensing overlays for pharmacies wishing to claim themselves as certified Ayurveda outlets.
When the billing counter is a single undifferentiated screen, the person entering the sale has no prompt to distinguish a classical Triphala churna from a branded allopathy OTC. The result:
- Batch numbers for AYUSH stock may not be logged to the AYUSH-specific purchase entry
- Return claims to distributors get rejected because the batch data on the AYUSH invoice doesn't match what the distributor sees
- Expiry tracking for slow-moving classical formulations (churnas, arishtams, tailas) runs on the same FIFO assumption as fast-moving allopathy strips — when AYUSH stock often demands FEFO (First Expiry First Out) discipline to avoid high-value spoilage
AYUSH stock often moves more slowly and in smaller quantities than allopathy strips, so a batch is more likely to reach its expiry month still on the shelf.
The DPDPA 2023 adds another layer: if your pharmacy stores patient prescription photographs digitally (increasingly common as UPI and digital prescription adoption grows), the data handling rules apply regardless of whether the prescription was for an allopathic or Ayurvedic product. A system without category-aware data handling may inadvertently mix prescription records in ways that create compliance exposure.
What a Solved Dual-Stock Pharmacy Actually Looks Like
Here is what to ask of any billing system (the next section says which of these Nesayo covers today):
| Workflow Step | Before | After |
|---|
| Billing a classical Ayurvedic product | Same screen as allopathy, same HSN default | AYUSH category auto-detected at product selection; correct HSN and rate pre-filled |
| Schedule register entry | Manual notebook for AYUSH restricted items | Auto-logged to correct register at point of sale |
| GSTR-1 filing prep | Accountant manually separates Ayurveda and allopathy lines | Two clean category reports exported, already split |
| Expiry management | FIFO across all stock | FEFO per batch per category; AYUSH slow-movers flagged separately |
| Distributor return documentation | Incomplete batch data, frequent rejections | Complete batch + category data on every return note |
The pharmacist at the counter doesn't need to know the HSN codes. The system does. The accountant's quarterly reconciliation becomes a review instead of a rebuild, and the records are current to the last transaction when the inspector asks.
That is what it looks like when the billing layer understands that "Ayurveda pharmacy" and "allopathy pharmacy" are not interchangeable contexts, even when they share a single counter.
How Nesayo Handles This Without a Separate Workflow
Picture the morning a distributor sends a partial credit note for an AYUSH return: the batch number on the pharmacy's invoice doesn't match what the distributor has on file, because the billing software pulled the product from the wrong purchase entry at the time of sale. Tracing it means paper invoices and phone calls.
On Nesayo, every bill line — allopathy or AYUSH — is sold from a specific batch, earliest expiry first (FEFO), and that batch number stays on the line. A batch whose expiry month has passed is refused at billing; a pack printed EXP 08/2026 stays sellable through 31 August 2026. On the AI Employee plan, the Expiry Guard agent sorts stock nearing expiry into 30, 60 and 90-day groups, with a discount or return suggestion, so the slow-moving arishtams and tailas show up while there is still time to act.
At the billing counter, one invoice carries both product types, and each line keeps its own HSN code, GST rate and batch. Ayurvedic products in the catalogue show an Ayurvedic badge. Ayurvedic brands are still being added to the catalogue, so a product that is not there yet is added once to your own medicine list with its HSN and GST rate. Schedule H1 sales are logged at billing (patient, prescriber, medicine, batch, quantity); the pharmacist adds the prescriber's address. Nesayo does not yet produce a separate AYUSH register or a category-split accounts export, so keep those records as your state requires.
When an Ayurvedic product is out of stock, the alternatives Nesayo offers are other Ayurvedic products for the same therapeutic purpose. It never suggests an allopathic medicine in place of an Ayurvedic one, or the other way round.
Billing on Nesayo is free, with no cap on invoices or products. The Starter plan at ₹399 per month (as of September 2026) adds voice billing, prescription scanning and Refill Radar. For pharmacies that want the full agent suite — all five AI agents including Morning Briefing, Expiry Guard, Refill Radar, Stock Sense, and Payment Advisor — the AI Employee plan runs ₹999 per month. (Prices as listed on nesayo.com/pricing, as of September 2026.)
The Choice Is Between Acting Now and Paying Later
Every month a dual-stock pharmacy runs on a single undifferentiated billing system is another month of GSTR-1 entries that may need correction, another month of AYUSH batch records that won't survive a distributor dispute, and another month of expiry risk accumulating in the classical formulations section of the shelf. The correction cost — in CA fees, penalties, and distributor rejection losses — can easily exceed what a year of correct software would have cost.
Spend 2 minutes at nesayo.com/demo — a sample pharmacy is pre-loaded, no signup required. Bill a mix of products and see how each line carries its own HSN code, GST rate and batch, picked earliest expiry first.
---
FAQ
What is the correct GST rate for Ayurvedic medicines in India?
Most Ayurvedic medicines sold in retail pharmacies fall under HSN 3004 at 5% GST. The old 12% slab was withdrawn from 22 September 2025 (Notification 9/2025-Central Tax (Rate), after the 56th GST Council), and ayurvedic, Unani, Siddha and homoeopathic medicaments under HSN 3003 and 3004 moved to 5%. However, the applicable rate can vary based on whether the product is a classical formulation, a proprietary AYUSH product, or an over-the-counter herbal product — and specific exemptions may apply to certain categories. Verify the exact classification for each product with your CA or refer to the GST tariff schedule and CBIC circulars, as blanket application of the allopathy rate to all AYUSH products is a common filing error.
Do Ayurvedic pharmacies in India need a separate drug license from allopathy pharmacies?
Yes, in most states, a separate license is required to stock and sell Ayurvedic, Siddha, and Unani (ASU) drugs — typically issued under the Drugs and Cosmetics Act provisions specific to ASU drugs, distinct from the retail drug license for allopathy. The specific licensing requirements vary by state. A pharmacy owner intending to operate as a combined outlet should verify with the state licensing authority whether a composite license is available or whether two separate licenses are required.
Is FEFO a legal requirement for pharmacies in India?
FEFO (First Expiry First Out) is not explicitly mandated as FEFO by name in the Drugs and Cosmetics Act or Rules for retail pharmacies, but the obligation to not sell or dispense expired drugs — combined with the requirement to maintain proper batch records — makes FEFO the operationally correct practice. For wholesale and manufacturing, Schedule M and Good Distribution Practices guidelines reinforce FEFO. For retail, the practical consequence of not following FEFO is expired stock reaching the customer, which is a D&C Act violation regardless of the inventory method used.
Can a single GST invoice include both Ayurvedic and allopathic medicines?
Yes, a single tax invoice can carry line items from both categories, provided each line item is correctly classified with its own HSN code and applicable GST rate. The problem arises when billing software applies a uniform HSN to all line items without distinguishing AYUSH products — that results in a technically incorrect invoice that may survive until a GSTR-2B reconciliation mismatch or a GST audit surfaces the error.
How should a retail pharmacy maintain the Schedule H register when it also stocks AYUSH restricted drugs?
The Schedule H and H1 records under Rule 65 of the D&C Rules apply to allopathic drugs on those schedules. Ayurvedic, Siddha and Unani medicines containing the poisonous ingredients listed in Schedule E(1) carry their own labelling rules. Keep AYUSH records separate rather than logging AYUSH dispensing into the allopathy H1 register, and confirm with your state licensing authority exactly what records it expects for them. Mixing the two is a record-keeping error that may not be immediately visible but creates compliance risk during inspection.
What happens if a distributor rejects an AYUSH return claim due to billing errors?
A distributor rejection on an AYUSH return typically happens when the batch number, purchase date, or product classification on the pharmacy's invoice does not match the distributor's records — often because the billing system pulled from the wrong purchase entry or applied an incorrect product code. Once rejected, recovering the credit requires manual tracing of physical invoices, which is time-consuming and often incomplete. The financial loss is the full value of the returned goods if the claim cannot be substantiated within the distributor's credit window.
How does a pharmacy's billing software affect GSTR-1 accuracy for AYUSH products?
GSTR-1 is filed based on the invoice data your billing software generates. If the software does not distinguish between AYUSH and allopathy product categories at the line-item level, the HSN summary in your GSTR-1 will aggregate both under the same codes. This creates a mismatch when your distributor or the GST portal cross-references HSN-level data against purchase records, and any department scrutiny of your HSN-wise sales summary will surface the inconsistency. Correcting filed returns through amendments is possible but carries a time limit and requires CA involvement.
Can Nesayo handle a pharmacy that sells both Ayurvedic and allopathic products on the same counter?
Yes. Both product types go through the same billing screen, and every line carries its own HSN code, GST rate and batch. Ayurvedic products in the catalogue show an Ayurvedic badge, and when one is out of stock the alternatives offered are other Ayurvedic products for the same purpose, never an allopathic medicine. Ayurvedic brands are still being added to the catalogue, so a product that is not there yet is added once to your own medicine list with its HSN and GST rate. Nesayo does not yet produce a separate AYUSH register or a category-split accounts export.